Use of the Antimicrobial Peptide Pardaxin (GE33) to Protect Against Methicillin-Resistant Staphylococcus Aureus Infection in Mice With Skin Injuries

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02427-13
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Efficacy of Antimicrobial Peptide DP7, Designed by Machine-Learning Method, Against Methicillin-Resistant Staphylococcus Aureus

Frontiers in Microbiology
Microbiology
2019English

Skin Infection in Children Colonized With Community-Associated Methicillin-Resistant Staphylococcus Aureus

Journal of Infection
Infectious DiseasesMicrobiology
2009English

Effects of the Antimicrobial Peptide L12 Against Multidrug‑resistant Staphylococcus Aureus

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

NP108, an Antimicrobial Polymer With Activity Against Methicillin- And Mupirocin-Resistant Staphylococcus Aureus

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

The Virulence of Methicillin-Resistant Staphylococcus Aureus in Mice

Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
Medicine
1986English

Community-Acquired Methicillin-Resistant Staphylococcus Aureus Infection

New England Journal of Medicine
Medicine
1993English

Staphylococcus Aureus Resistant to Methicillin.

BMJ
1991English

Problems in Assessing Rates of Infection With Methicillin Resistant Staphylococcus Aureus

BMJ
2005English

Methicillin-Resistant Staphylococcus Aureus

The Lancet
Medicine
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy